Caption Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 699 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 677 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 588 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 552 |
|
|
2024
Q1 | – | Sell |
-31,600
| Closed | -$94.5K | – | 573 |
|
|
2023
Q4 | $94.5K | Buy |
+31,600
| New | +$94.5K | ﹤0.01% | 346 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 560 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 493 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 509 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 569 |
|
|
2022
Q3 | – | Sell |
-12,300
| Closed | -$78K | – | 640 |
|
|
2022
Q2 | $78K | Buy |
+12,300
| New | +$78K | ﹤0.01% | 412 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 670 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 693 |
|
|
2021
Q3 | – | Sell |
-25,589
| Closed | -$542K | – | 664 |
|
|
2021
Q2 | $542K | Buy |
25,589
+939
| +4% | +$19.9K | 0.01% | 252 |
|
|
2021
Q1 | $691K | Buy |
+24,650
| New | +$691K | 0.01% | 192 |
|
|
2020
Q4 | – | Sell |
-3,000
| Closed | -$111K | – | 434 |
|
|
2020
Q3 | $111K | Sell |
3,000
-18,504
| -86% | -$685K | ﹤0.01% | 298 |
|
|
2020
Q2 | $1.1M | Buy |
21,504
+7,804
| +57% | +$400K | 0.04% | 99 |
|
|
2020
Q1 | $431K | Buy |
+13,700
| New | +$431K | 0.02% | 157 |
|
|
2019
Q4 | – | Sell |
-4,400
| Closed | -$161K | – | 375 |
|
|
2019
Q3 | $161K | Buy |
+4,400
| New | +$161K | 0.01% | 205 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 309 |
|
|
2019
Q1 | – | Sell |
-15,000
| Closed | -$690K | – | 268 |
|
|
2018
Q4 | $690K | Buy |
+15,000
| New | +$690K | 0.06% | 91 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 262 |
|